1. Home
  2. HRB vs FOLD Comparison

HRB vs FOLD Comparison

Compare HRB & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$36.84

Market Cap

4.0B

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
FOLD
Founded
1955
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
HRB
FOLD
Price
$36.84
$14.49
Analyst Decision
Sell
Buy
Analyst Count
2
9
Target Price
$41.00
$27.25
AVG Volume (30 Days)
2.4M
2.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
5.34%
N/A
EPS Growth
6.55
50.00
EPS
3.38
N/A
Revenue
$3,159,931,000.00
N/A
Revenue This Year
$4.39
$20.50
Revenue Next Year
$3.21
$18.59
P/E Ratio
$10.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$5.66
52 Week High
$59.05
$14.50

Technical Indicators

Market Signals
Indicator
HRB
FOLD
Relative Strength Index (RSI) 64.49 74.18
Support Level $29.24 $14.21
Resistance Level $44.16 N/A
Average True Range (ATR) 1.70 0.02
MACD 0.53 -0.00
Stochastic Oscillator 87.93 100.00

Price Performance

Historical Comparison
HRB
FOLD

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: